Ergomed announced that, following an exercise of share options, application has been made to AIM for the admission of 450,000 new ordinary shares of 1p each in the capital of the company (New Ordinary Shares).
Subsequent to the Admission, the New Ordinary Shares will rank on par in all respects with the company’s existing ordinary shares.
Following Admission, the total number of ordinary shares with voting rights in issue will be 47,757,177. The aforementioned figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Besides the New Ordinary Shares, this figure includes 20,888 ordinary shares issued since 31 December 2019 and admitted to AIM pursuant to the company’s block listing in respect of the Ergomed Long Term Incentive Plan.